$ORCL

Monday's Stock to Watch: Oracle, Blue Owl, and Apollo

Oracle (ORCL) announced an additional $700M restructuring charge due to layoffs, potentially impacting its stock. Blue Owl (OWL) saw a 10.81% drop in stock value, closing at $10.56, amid loan write-down concerns. Apollo (APO) is in talks to acquire J&J’s (JNJ) orthopedics unit, with mixed performance in the medical devices sector.

Original reporting
Published Sep 17, 2026, 5:00 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Sep 17, 2026, 5:12 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Monday's Stock to Watch: Oracle, Blue Owl, and Apollo — source image
Decision brief

The 30-second read

$ORCLBearishHigh
01

Why it matters

Each company faces distinct catalysts: a large restructuring charge, a loan write‑down, and M&A talks, influencing short‑term price action.

02

Market read

All three tickers show material news that could drive immediate trading decisions.

03

What to watch

Potential cost synergies from AI investments and Apollo's deal could offset short‑term pain.

Relevance 8/10Novelty 8/10Timing: post‑earnings today

Background

The article aggregates recent corporate news affecting three publicly traded U.S. companies.

Company-level read

Ticker impact

$ORCLBearishHigh confidence
Context

Oracle announced an additional $700M restructuring charge, increasing its post‑earnings sell‑off risk.

Expected impact

downward pressure, possible 3‑5% drop over next few days

Evidence & confidence

Large, unexpected charge signals weaker profitability and may trigger margin concerns.

$OWLBearishMedium confidence
Context

Blue Owl's stock fell 10.81% after a loan write‑down and concerns over additional write‑downs.

Expected impact

further short‑term decline, 2‑4% pullback likely

Evidence & confidence

Recent loss and write‑down news suggest deteriorating loan portfolio performance.

$APOBullishMedium confidence
Context

Apollo Management entered talks to acquire Johnson & Johnson's orthopedics unit.

Expected impact

potential upside of 3‑6% on news flow

Evidence & confidence

M&A speculation often lifts share price; size of target adds material interest.

Market effects

Tech restructuring may pressure other software firms; credit‑market stress could affect other loan‑focused managers.

U.S. markets may see broader sell‑off in tech and financials.

Limited to U.S. equities, no immediate global macro effect.

Counterpoint

Oracle's charge may be a one‑time expense that improves long‑term margins; short sellers could be overreacting.

Key entities

  • Oracle

    Enterprise software and cloud services provider.

  • Blue Owl

    Private credit manager.

  • Apollo Management

    Alternative investment manager.

Related articles

$ORCLHighAI 8/10

Larry Ellison cancels plan to sell up to $7.5bn of Oracle stock

Larry Ellison, Oracle's Executive Chair, canceled a plan to sell up to $7.5bn of Oracle (NYSE: ORCL) stock, according to the company. The plan, covering 50 million shares, was announced on 22 June 2026 and canceled on 12 September 2026. Oracle reported Q1 2026 revenue of $19.345bn, up from $14.926bn a year earlier, with net income rising to $4.76bn from $2.927bn. The company's cloud infrastructure unit grew 121% year-on-year to $7.4bn.

$ORCLMedAI 8/10

After $664 billion backlog, Oracle sends shocking message to staff

Oracle announced another round of layoffs, reducing its workforce by 13% in fiscal 2026, with severance costs reaching $1.8 billion. The company is investing heavily in AI data centers, raising $48 billion in debt and equity to fund its $90-95 billion capital expenditure forecast for fiscal 2027. Despite a $553 billion backlog, Oracle's stock has fallen due to concerns over its debt load and negative free cash flow, with analysts divided on its outlook.

$ORCLHighAI 9/10

Oracle’s Q1 Results Prove the AI Trade Is Going Nowhere

Oracle reported Q1 earnings of $1.92 per share, beating estimates, with revenues up 30%. Margins held steady despite higher capital expenditures. Free cash flow remained negative, and debt increased. The company raised EPS guidance for FY 2026. Analysts rate ORCL a 'Strong Buy' with a mean target price of $247.19, citing undervaluation but noting risks from debt and negative cash flow.

$ORCLMed

Oracle Rallies 2% as Restructuring Helps Finance the AI Sprint

Oracle (ORCL) shares rose 2.1% to $143.33 as restructuring costs increased by $700M to $2.8B, while data-center capacity expanded by 850 megawatts. Quarterly revenue was $19.35B, with free cash flow around -$5B. The company secured $30B in AI-cloud contracts, boosting backlog to $664B, but faces challenges in converting this into profitable revenue.

$ORCLMed

Oracle CFO Hilary Maxson addresses layoffs at first company meeting

Oracle CFO Hilary Maxson addressed employees, emphasizing process simplification and strategic resource allocation. The company recently began new layoffs, part of a broader workforce reduction of 21,000 positions (13%) in the past fiscal year. Oracle expanded its 2026 Restructuring Plan by $700 million, with total costs reaching $2.8 billion. Capital expenditures rose to $28.5 billion in the latest quarter, up from $8.5 billion a year earlier, with fiscal 2027 outlay projected at $90 billion to

$ORCLHighAI 9/10

Key facts: Oracle (ORCL) capex guidance $95B; Java 27 launch

Oracle (ORCL) reported Q1 capex of $28.5B and raised fiscal 2027 capex guidance to $95B. The company launched Java 27 with AI features and performance improvements. Analysts mostly rate ORCL as Buy, with a consensus price target near $239. Oracle is investing in Texas wind projects to power AI data centers and aims for 100% carbon-free AI power by 2035.